PCSK9: A link between air pollution and cardiovascular disease?

被引:0
|
作者
Prochaska, Juergen H. [1 ,2 ,3 ]
Troebs, Sven-Oliver [3 ,4 ]
Wild, Philipp S. [1 ,2 ,3 ]
机构
[1] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Prevent Cardiol & Prevent Med, Mainz, Germany
[2] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Ctr Thrombosis & Hemostasis, Mainz, Germany
[3] German Ctr Cardiovasc Res DZHK, Partner Site Rhein Main, Berlin, Germany
[4] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Ctr Cardiol, Cardiol 1, Mainz, Germany
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:576 / 577
页数:2
相关论文
共 50 条
  • [31] PCSK9 and Cardiovascular Disease in Individuals with Moderately Decreased Kidney Function
    Kheirkhah, Azin
    Lamina, Claudia
    Kollerits, Barbara
    Schachtl-Riess, Johanna F.
    Schultheiss, Ulla T.
    Forer, Lukas
    Sekula, Peggy
    Kotsis, Fruzsina
    Eckardt, Kai-Uwe
    Kronenberg, Florian
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 17 (06): : 809 - 818
  • [32] The Link Between Air Pollution and Cardiovascular Diseases
    Ebeigbe, Anthony B.
    [J]. TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2008, 7 (04) : 1105 - 1106
  • [33] PCSK9 AND INDICES OF CARDIOVASCULAR MORBIDITY IN PATIENTS WITH CHRONIC KIDNEY DISEASE
    Dounousi, Evangelia
    Papanikolaou, Sarantis
    Tellis, Kostas
    Duni, Anila
    Pavlakou, Paraskevi
    Tatsioni, Athina
    Tselepis, Alexandros
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34 : 168 - 168
  • [34] PCSK9: A Key Modulator of Cardiovascular Health
    Seidah, Nabil G.
    Awan, Zuhier
    Chretien, Michel
    Mbikay, Majambu
    [J]. CIRCULATION RESEARCH, 2014, 114 (06) : 1022 - 1036
  • [35] PCSK9 Inhibitors: Potential in Cardiovascular Therapeutics
    Do, Rose Q.
    Vogel, Robert A.
    Schwartz, Gregory G.
    [J]. CURRENT CARDIOLOGY REPORTS, 2013, 15 (03)
  • [36] PCSK9 Inhibitors: Potential in Cardiovascular Therapeutics
    Rose Q. Do
    Robert A. Vogel
    Gregory G. Schwartz
    [J]. Current Cardiology Reports, 2013, 15
  • [37] PCSK9 Inhibitors and Cardiovascular Events Reply
    Sabatine, Marc S.
    Wasserman, Scott M.
    Stein, Evan A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (08): : 774 - 775
  • [38] PCSK9 Inhibition to Reduce Cardiovascular Events
    Dullaart, Robin P. F.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (18): : 1790 - 1791
  • [39] HMGCR and PCSK9 variants and cardiovascular risk
    不详
    [J]. NATURE REVIEWS CARDIOLOGY, 2017, 14 (02) : 66 - 66
  • [40] Effects of PCSK9 Inhibition on Plasma PCSK9 Concentration and Hepatic PCSK9 Expression
    Shapiro, Michael D.
    Tavori, Hagai
    Oleaga, Carlota
    Miles, Joshua
    Fazio, Sergio
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2018, 38